Psoriasis in Primary Care: A Quiz

How is psoriasis best managed in the primary care setting? Take this quick quiz to test your knowledge.

For more information:Hackethal V. Psoriasis: a primary care primer. Rheumatology Network. April 30, 2018. Accessed August 21, 2018.

Related Videos
Related Content

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023

ACR/AAHKS Introduces Guidelines for Optimal Timing of Knee and Hip Arthroplasty

March 28th 2023

Overdrive Podcast: What's Limiting Medical Marijuana Therapy in Rheumatology?

May 19th 2022

Match Day's Hidden Crisis: Pediatric Rheumatology Struggling to Meet Pace

March 17th 2023

Overdrive Podcast: ArthritisPower Redesign and Research

April 11th 2022

Tumor Necrosis Factor Inhibitors Safely, Effectively Treat Patients With Juvenile Idiopathic Arthritis

March 1st 2023

Sindhu Ramchandren, MD: Nipocalimab may be a Promising New Treatment Option for Myasthenia Gravis

February 28th 2023
© 2023 MJH Life Sciences

All rights reserved.